Mainz Biomed N.V.
MYNZ
$4.37
-$0.365-7.72%
| 12/31/2023 | 12/31/2022 | 09/30/2022 | |||
|---|---|---|---|---|---|
| Net Income | 36.70% | -43.30% | -20.62% | ||
| Total Depreciation and Amortization | -16.36% | 1,297.14% | 806.86% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -94.51% | -61.80% | -51.11% | ||
| Change in Net Operating Assets | -85.48% | 2,460.64% | 848.54% | ||
| Cash from Operations | 1.21% | -205.22% | -169.21% | ||
| Capital Expenditure | -993.24% | -142.62% | -3,227.87% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -1,668.92% | -102.45% | -133.61% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -844.02% | -488.71% | -298.39% | ||
| Issuance of Common Stock | -- | -- | -100.00% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 3,265.11% | -102.11% | -101.43% | ||
| Foreign Exchange rate Adjustments | -2,740.93% | -395.79% | -88.42% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 53.76% | -214.03% | -203.90% | ||
